Adjuvant endocrine therapy

Karen Lisa Smith, Vered Stearns

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Endocrine therapy is a key component of the adjuvant treatment of early-stage breast cancer. In this chapter, we review the current approach to adjuvant endocrine therapy for early-stage invasive breast cancer and ductal carcinoma in situ. We also review key trials leading to the development of current treatments and review toxicities and unanswered questions. Emphasis is placed on differences in the approaches to adjuvant endocrine therapy in pre- and postmenopausal women.

Original languageEnglish (US)
Title of host publicationThe Breast
Subtitle of host publicationComprehensive Management of Benign and Malignant Diseases
PublisherElsevier Inc.
Pages736-751.e4
ISBN (Print)9780323359559
DOIs
StatePublished - 2018

Keywords

  • Adjuvant endocrine therapy
  • Aromatase inhibitor
  • Breast cancer
  • Ovarian suppression
  • Tamoxifen

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Adjuvant endocrine therapy'. Together they form a unique fingerprint.

Cite this